This company listing is no longer active
Resumen de acción U4W0
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Quotient Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €0.12 |
| 52 Week High | €15.36 |
| 52 Week Low | €0.018 |
| Beta | 1.36 |
| 1 Month Change | 313.79% |
| 3 Month Change | 196.30% |
| 1 Year Change | -99.22% |
| 3 Year Change | -99.96% |
| 5 Year Change | -99.96% |
| Change since IPO | -99.92% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| U4W0 | DE Medical Equipment | Mercado DE | |
|---|---|---|---|
| 7D | 0% | 2.4% | 1.1% |
| 1Y | -99.2% | -8.5% | 1.9% |
Rentabilidad vs. Industria: U4W0 underperformed the German Medical Equipment industry which returned 9.3% over the past year.
Rentabilidad vs. Mercado: U4W0 underperformed the German Market which returned 1.9% over the past year.
Volatilidad de los precios
| U4W0 volatility | |
|---|---|
| U4W0 Average Weekly Movement | 95.4% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Precio estable de las acciones: U4W0's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: U4W0's weekly volatility has increased from 63% to 95% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2007 | 432 | Manuel Mendez | www.quotientbd.com |
Resumen de fundamentos de Quotient Limited
| Estadísticas fundamentales de U4W0 | |
|---|---|
| Capitalización bursátil | €2.53m |
| Beneficios(TTM) | -€112.90m |
| Ingresos (TTM) | €34.05m |
0.1x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está U4W0 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de U4W0 | |
|---|---|
| Ingresos | US$37.41m |
| Coste de los ingresos | US$37.13m |
| Beneficio bruto | US$279.00k |
| Otros gastos | US$124.31m |
| Beneficios | -US$124.03m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -5.89 |
| Margen bruto | 0.75% |
| Margen de beneficio neto | -331.54% |
| Ratio deuda/patrimonio | -126.2% |
¿Cómo se ha desempeñado U4W0 a largo plazo?
Ver rendimiento histórico y comparativa